Bleichroeder LP
13F holdings for Q2 2026 · NEW YORK, NY · filed August 13, 2026
Bleichroeder LP reported $559M in 13F securities across 78 holdings for Q2 2026, in a Form 13F filed August 13, 2026. The largest positions were SPDR Gold TR (31.3%), GPGI (11.3%), SPY (9.0%). Reported value fell 3.4% from the quarter before. It opened 9 new positions, added to 7, trimmed 7 and sold out of 12.
- 13F value Q2 2026
- $559M
- Holdings
- 78
- Change vs prior quarter
- -3.4%
- Rank by 13F value
- #3,610
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Top holdings
| Stock | Value | Weight | Shares | Change in shares | Move |
|---|---|---|---|---|---|
| SPDR Gold TR | $175M | 31.3% | 475,000 | 0% | Unchanged |
| GPGI GPGI Inc. | $63.0M | 11.3% | 3,972,176 | 0% | Unchanged |
| SPY State Street SPDR S&P 500 ETF Trust Unit | $50.5M | 9.0% | 67,645 | 0% | Unchanged |
| RHLD Resolute Holdings Management | $45.4M | 8.1% | 314,166 | 0% | Unchanged |
| Linde PLC SHS | $31.4M | 5.6% | 60,434 | -11.7% | Trimmed |
| DUOT Duos Technologies Group Inc. | $19.5M | 3.5% | 1,627,806 | 0% | Unchanged |
| DTIL Precision BioSciences Inc. | $15.9M | 2.8% | 2,018,190 | +21.4% | Added |
| CUE Cue Biopharma Inc. | $11.7M | 2.1% | 370,682 | New | New |
| BX Blackstone Inc. | $10.7M | 1.9% | 90,750 | 0% | Unchanged |
| IMMX Immix Biopharma Inc. | $10.3M | 1.8% | 1,000,000 | 0% | Unchanged |
| IDN Intellicheck Inc. | $8.4M | 1.5% | 2,056,343 | -0.8% | Trimmed |
| SPGI S&P Global Inc. | $8.1M | 1.5% | 20,000 | 0% | Unchanged |
| INVE INVE Technologies Inc. | $7.3M | 1.3% | 2,884,495 | 0% | Unchanged |
| LIQT LiqTech International Inc. | $5.8M | 1.0% | 6,882,239 | +116.3% | Added |
| KZIA Kazia Therapeutics Limited | $5.6M | 1.0% | 400,000 | 0% | Unchanged |
| Envoy Medical Inc | $5.0M | 0.9% | 6,250,000 | 0% | Unchanged |
| CGEM Cullinan Therapeutics Inc. | $4.6M | 0.8% | 250,000 | +150.0% | Added |
| WELL Welltower Inc. | $4.5M | 0.8% | 20,000 | 0% | Unchanged |
| EYPT EyePoint Inc. | $4.5M | 0.8% | 316,515 | 0% | Unchanged |
| FLNT Fluent Inc. | $4.3M | 0.8% | 1,142,857 | -20.0% | Trimmed |
| GNLX Genelux Corporation | $4.2M | 0.7% | 1,380,666 | 0% | Unchanged |
| PROK ProKidney Corp. | $4.1M | 0.7% | 2,000,000 | 0% | Unchanged |
| COGT Cogent Biosciences Inc. | $3.9M | 0.7% | 100,000 | New | New |
| QQQ Invesco QQQ Trust, Series 1 | $3.4M | 0.6% | 4,640 | 0% | Unchanged |
| JPM JP Morgan Chase & Co. | $3.3M | 0.6% | 10,200 | -32.0% | Trimmed |
Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $559M in share positions; options and bonds count in the 13F value but not here.
Biggest buys in Q2 2026
- CUE Cue Biopharma Inc. New+$11.7M
- COGT Cogent Biosciences Inc. New+$3.9M
- LIQT LiqTech International Inc. Added+$3.1M
- DTIL Precision BioSciences Inc. Added+$2.8M
- CGEM Cullinan Therapeutics Inc. Added+$2.7M
- SPIR Spire Global Inc. New+$2.5M
- NMTC NeuroOne Medical Technologies Corporation New+$2.0M
- DETX Liberty Defense Holdings Ltd. New+$1.1M
- RNTX Rein Therapeutics Inc. New+$1.0M
- Sintx Technologies Inc New+$978K
Biggest sells in Q2 2026
- Linde PLC SHS Trimmed-$4.2M
- Neuroone Med Technologies Corp Com Sold out-$3.1M
- JPM JP Morgan Chase & Co. Trimmed-$1.6M
- Cue Biopharma Inc Sold out-$1.6M
- POCI Precision Optics Corporation Inc. Sold out-$1.2M
- RTX RTX Corporation Sold out-$1.2M
- FLNT Fluent Inc. Trimmed-$1.1M
- PXLW Pixelworks Inc. Trimmed-$728K
- SHAZ SharonAI Holdings Inc. Sold out-$568K
- LHX L3Harris Technologies Inc. Sold out-$552K
The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 9 new, 7 added, 7 trimmed, 12 sold out.
Sector mix
- Not listed with us39.4%
- Finance23.4%
- Health Care14.1%
- Funds and other9.0%
- Technology8.4%
- Industrials1.8%
- Consumer Discretionary1.8%
- Real Estate0.8%
- n/a0.6%
- Consumer Staples0.5%
13F value by quarter
More holdings
| Stock | Value | Weight | Shares | Change in shares | Move |
|---|---|---|---|---|---|
| Mdxhealth SA | $3.0M | 0.5% | 7,378,333 | 0% | Unchanged |
| IRD Opus Genetics Inc. | $3.0M | 0.5% | 736,842 | 0% | Unchanged |
| TV Grupo Televisa S.A.B. | $2.8M | 0.5% | 1,030,000 | 0% | Unchanged |
| BRFH Barfresh Food Group Inc. | $2.8M | 0.5% | 1,390,758 | 0% | Unchanged |
| DMAC DiaMedica Therapeutics Inc. | $2.7M | 0.5% | 382,317 | 0% | Unchanged |
| ROC Rank One Computing Corporation | $2.6M | 0.5% | 500,000 | 0% | Unchanged |
| SPIR Spire Global Inc. | $2.5M | 0.4% | 135,000 | New | New |
| IPWR Ideal Power Inc. | $2.1M | 0.4% | 400,000 | +33.3% | Added |
| NMTC NeuroOne Medical Technologies Corporation | $2.0M | 0.4% | 666,666 | New | New |
| Curis Inc | $2.0M | 0.4% | 3,802,329 | 0% | Unchanged |
| Revolution Medicines Inc | $1.9M | 0.3% | 200,000 | 0% | Unchanged |
| PROF Profound Medical Corp. | $1.7M | 0.3% | 254,753 | 0% | Unchanged |
| RNXT RenovoRx Inc. | $1.6M | 0.3% | 1,666,098 | 0% | Unchanged |
| MODD Modular Medical Inc. | $1.5M | 0.3% | 336,986 | +80.2% | Added |
| VENU Venu Holding Corporation | $1.4M | 0.2% | 600,000 | 0% | Unchanged |
| TLPH Talphera Inc. | $1.3M | 0.2% | 1,307,787 | 0% | Unchanged |
| QTI QT Imaging Holdings Inc. | $1.3M | 0.2% | 316,667 | +90.0% | Added |
| LLYVK Liberty Live Holdings Inc. | $1.2M | 0.2% | 13,802 | 0% | Unchanged |
| DETX Liberty Defense Holdings Ltd. | $1.1M | 0.2% | 277,777 | New | New |
| RNTX Rein Therapeutics Inc. | $1.0M | 0.2% | 1,000,000 | New | New |
| OWLT Owlet Inc. | $987K | 0.2% | 172,000 | 0% | Unchanged |
| Sintx Technologies Inc | $978K | 0.2% | 523,013 | New | New |
| CLRB Cellectar Biosciences Inc. | $803K | 0.1% | 288,679 | +188.7% | Added |
| MAIA MAIA Biotechnology Inc. | $720K | 0.1% | 500,000 | 0% | Unchanged |
| FEAM 5E Advanced Materials Inc. | $638K | 0.1% | 458,774 | -8.2% | Trimmed |
Showing the 50 largest of 78 share positions. The full filing on SEC EDGAR
Schedule 13D and 13G filings by Bleichroeder LP
Stakes above 5% of a company, filed within days rather than once a quarter.
- 2026-08-14MDXH SCHEDULE 13D filed by MDxHealth SASchedule 13D
- 2026-05-14COCH SCHEDULE 13G filed by Envoy Medical Inc.Schedule 13G
- 2025-03-31SMTK SCHEDULE 13G filed by SmartKem Inc.Schedule 13G
Questions about Bleichroeder LP
- What does Bleichroeder LP own?
- In its Form 13F for Q2 2026, Bleichroeder LP reported 78 holdings worth $559M. The five largest were SPDR Gold TR, GPGI, SPY, RHLD, Linde PLC SHS.
- What did Bleichroeder LP buy and sell in Q2 2026?
- Bleichroeder LP opened 9 new positions, added to 7, trimmed 7 and sold out of 12 compared with the quarter before.
- When did Bleichroeder LP file its latest 13F?
- Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed August 13, 2026.
From Form 13F filed by Bleichroeder LP (SEC CIK 0001781002) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds